NasdaqGM - Nasdaq Real Time Price USD
Entrada Therapeutics, Inc. (TRDA)
8.74
+0.03
+(0.37%)
As of 12:30:22 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DOSHI DIPAL Chief Executive Officer | Stock Award(Grant) | Feb 28, 2025 | 424,387 |
| DOWDEN NATHAN J President | Stock Award(Grant) | Feb 28, 2025 | 180,805 |
| KIM PETER S Director | Conversion of Exercise of derivative security | Jun 3, 2024 | 104,330 |
| KREHER NERISSA C Officer | Sale | Sep 6, 2023 | 40,037 |
| MPM BIOVENTURES III, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 11, 2024 | -- |
| SETHURAMAN NATARAJAN Officer | Stock Award(Grant) | Feb 28, 2025 | 199,659 |
| WENTWORTH KORY JAMES Chief Financial Officer | Conversion of Exercise of derivative security | Apr 3, 2025 | 120,670 |
Related Tickers
SYBX Synlogic, Inc.
1.1600
+3.57%
AURA Aura Biosciences, Inc.
5.54
-3.81%
ACRV Acrivon Therapeutics, Inc.
1.9194
-4.03%
TYRA Tyra Biosciences, Inc.
9.96
-0.60%
0RA.F RAPT Therapeutics, Inc.
0.7500
+7.14%
38I.DU Intellia Therapeutics Inc
7.15
-2.05%
1U5.SG Wave Life Sciences Ltd.
6.00
-2.44%
ADXN.SW Addex Therapeutics Ltd
0.0504
-5.26%
PMVP PMV Pharmaceuticals, Inc.
1.0700
0.00%
SYRE Spyre Therapeutics, Inc.
14.77
+3.83%